A Glasgow, Kentucky drug wholesaler is taking the federal government to court after the DEA shut them down — and the story involves a wild phishing scam, 60,000 stolen oxycodone pills, and a family business on the brink.
Glasgow Pharmaceutical Company Richie Pharmacal Files Federal Lawsuit Against DEA and Department of Justice
A 50-year-old family-owned pharmaceutical distributor in Glasgow, Kentucky is fighting for its survival after the Drug Enforcement Administration issued an Immediate Suspension Order that halted all operations.
Richie Enterprises LLC, also known as Richie Pharmacal, filed a federal lawsuit on March 31, 2026 against the U.S. Department of Justice and the DEA in the U.S. District Court for the District of Columbia. The Glasgow-based company claims the government acted “arbitrarily and capriciously” by shutting down their ability to distribute controlled substances without a prior hearing.
The lawsuit names Attorney General Pamela Bondi and DEA Administrator Terrance C. Cole as defendants.
What Is an Immediate Suspension Order? DEA Emergency Action Explained
An Immediate Suspension Order (ISO) is an emergency administrative action that immediately suspends a DEA registrant’s authority to handle controlled substances. Under federal law, the DEA can only issue an ISO when there is “imminent danger to the public health or safety” — meaning a substantial likelihood of immediate death or serious bodily harm.
The DEA issued the suspension order against Richie Pharmacal on February 10, 2026, citing violations of the Controlled Substances Act at their Glasgow distribution facility.
Richie Enterprises argues the DEA provided no evidence to support such a high legal threshold.
The Phishing Scam: How a Fake DEA Agent Stole 60,000 Oxycodone Pills
Here’s where the story takes a dramatic turn.
According to court documents, the DEA’s case against Richie partly stems from a sophisticated phishing scheme that occurred in October 2025. An imposter posed as a DEA special agent and convinced Richie Pharmacal employees that they were setting up a legitimate “sting” operation.
The result? The scammer successfully stole 60,000 oxycodone pills from the Glasgow facility.
While the DEA claims Richie failed to report the theft in a timely manner, Richie asserts in court filings that they notified the DEA’s Louisville field office within 24 hours and filed a written report shortly after.
DEA Investigation: What Else Did Federal Investigators Find?
Beyond the phishing incident, the DEA’s case against Richie Pharmacal includes additional allegations:
- Sales made to DEA personnel posing as customers between 2023 and 2024, where the agency alleges Richie failed to perform proper due diligence
- Filling orders for a customer with a valid DEA registration but an invalid state license between 2020 and 2022
The DEA’s Louisville Field Division stated in February that “Richie Pharmacal’s actions in this case contributed to the diversion of medications often linked with abuse, threatened the safety of our community, and endangered American lives.”
Richie Pharmacal’s Legal Defense: Fifth Amendment Due Process Violation
Richie Enterprises is arguing that the DEA violated their Fifth Amendment due process rights. Although the suspension took effect in early February, the company claims that nearly 50 days passed without the DEA assigning an Administrative Law Judge or setting a firm hearing date.
On April 1, 2026, Richie filed a motion requesting a preliminary injunction that would:
- Dissolve the Immediate Suspension Order
- Return their DEA Certificate of Registration
- Return their controlled substance inventory
- Prevent enforcement of the order during legal proceedings
A hearing on the preliminary injunction is set for April 14, 2026.
Economic Impact: 30 Kentucky Jobs at Risk, One of Industry’s Oldest Distributors May Close
Richie Pharmacal employs 30 people in Kentucky and has been operating for five decades, making it one of the pharmaceutical distribution industry’s oldest independent distributors.
In court filings, the company states: “Richie has faced irreparable harm to its business, including the loss of customers, sales, and revenue that it will never recover, and company goodwill.”
The company warns that continued enforcement of the Immediate Suspension Order during administrative proceedings could lead to permanent closure.
What Happens Next? Court Hearing Set for April 14
The DOJ and DEA have not yet filed a formal response in court. Kevin McWilliams, public information officer for the DEA’s Louisville Field Office, declined to comment on pending litigation.
The preliminary injunction hearing is scheduled for April 14, 2026 in U.S. District Court for the District of Columbia.
The Bottom Line
This case sits at the intersection of federal drug enforcement, pharmaceutical supply chain security, and small business survival. Whether Richie Pharmacal was the victim of a sophisticated scam or failed to meet its regulatory obligations — or both — will be decided in federal court.
What’s clear is that 30 jobs and a 50-year Kentucky business hang in the balance.
Related: McConnell Announces $20 Million for Cave City Agriculture Expo Center
Stay informed. Stay sharp. This is the TEG Report.
Sources: WBKO, WCLU Radio, Glasgow News 1, U.S. District Court for the District of Columbia